DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-4,028 Cr | ₹-4,137 Cr | ₹-2,639 Cr | ₹-2,266 Cr | ₹-492 Cr |
What is the latest Cash Flow from Investing Activities ratio of DR REDDYS LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-4,028 Cr |
Mar2023 | ₹-4,137 Cr |
Mar2022 | ₹-2,639 Cr |
Mar2021 | ₹-2,266 Cr |
Mar2020 | ₹-492 Cr |
How is Cash Flow from Investing Activities of DR REDDYS LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-4,028 Cr | Negative | |
Mar2023 | ₹-4,137 Cr | Negative | |
Mar2022 | ₹-2,639 Cr | Negative | |
Mar2021 | ₹-2,266 Cr | Negative | |
Mar2020 | ₹-492 Cr | - |
Compare Cash Flow from Investing Activities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹110,079.6 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics | |
MANKIND PHARMA | ₹97,090.3 Cr | -1.1% | -8.1% | 6.5% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -2.3% |
8.2% |
11.1% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses